Balcar L, Mandorfer M, Hernández-Gea V, Procopet B, Meyer EL, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Ibáñez-Samaniego L, Silva-Junior G, Martinez J, Genescà J, Bureau C, Trebicka J, Llop-Herrera E, Laleman W, Palazón-Azorín JM, Castellote-Alonso J, Gluud LL, Noronha-Ferreira C, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, GRøNBæK H, Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo M, Gonzalez-Abraldes J, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Nevens F, Calleja JL, Jansen C, Vega-Catalina M, Albillos A, Rudler M, Alvarado-Tapias E, Guardascione MA, Tantau M, Schwarzer R, Reiberger T, Laursen SB, Lopez-Gomez M, Cachero A, Ferrarese A, Ripoll C, la Mura V, Bosch J, García-Pagán JC
*, International Variceal Bleeding Observational Study Group by the Baveno Cooperation: an EASL consortium.
Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding. J Hepatol 2024; 80(1): 73-81.